Lyophilized Sterile Vial
Tested: 99.4% Average Assay
Current Lot: MV-2026-GAN15-02
Multi-Peptide Precision Synergy
Gain Hypertrophy Blend (Tesa + Ipam + GHRP-2 + MGF)
15mg / 5mL Lyophilized Multi-Compound • HPLC Purity: 99.4% Average Assay • Target: ≥ 99.0% per component
Four-component peptide matrix designed to explore maximum somatotropic response, GH peak amplitude, and downstream IGF-1 local autocrine signaling.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula Quad Secretagogue Complex
Molecular Weight Co-Lyophilized Matrix
CAS Registry # Multi-CAS Blend
Peptide Sequence / Structure Tesamorelin (6mg) + Ipamorelin (4mg) + GHRP-2 (3mg) + MGF (2mg)
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-GAN15-02 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Four-Component HPLC Assay | Conforms (All >99.0%) | RP-HPLC Quad Gradient | Conforms |
| Mass Spec Fingerprint | 4 Validated Peaks | ESI-MS Fingerprint | Conforms |
| Endotoxin Level | < 0.05 EU/mg | LAL Kinetic | Conforms |
Biological Mechanism of Action
Dual-class secretagogue excitation paired with local IGF-1Ec splice variant (MGF) activity.
Research Focus Areas: Quad Secretagogue Peak Amplitude Autocrine IGF-1
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for Gain Blend.